NASDAQ:TRIV - Trivascular Technologies Stock Price, Price Target & More

$5.87 +0.42 (+7.71 %)

(As of 04/19/2018 11:00 AM ET)

Previous Close$5.45

Today's Range$5.31 - $5.95

52-Week Range$3.98 - $11.49

Volume24,500 shs

Average Volume18,900 shs

Market Capitalization$120.75 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

About Trivascular Technologies (NASDAQ:TRIV)

Trivascular Technologies, Inc. is a medical device company developing and commercializing technologies to advance minimally invasive treatment of abdominal aortic aneurysms (AAA). The Ovation System, the Company's solution for the treatment of AAA through minimally invasive endovascular aortic repair, or EVAR, is a stent graft platform, providing an alternative to conventional devices. It is designed to specifically address many of the limitations associated with conventional EVAR devices and expand the pool of patients eligible for EVAR. The Company is developing Ovation iX iliac limbs for use with both its Ovation Prime and its Ovation iX and Alto aortic bodies, which are in development. Trivascular is developing Ovation iX aortic bodies for use with both its Ovation Prime and its Ovation iX iliac limbs. The Company is developing an aortic body that together with the iliac limbs makes up the Ovation Alto stent graft.

Receive TRIV News and Ratings via Email

Sign-up to receive the latest news and ratings for TRIV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A

Sub-IndustryN/A

SectorN/A

SymbolNASDAQ:TRIV

CUSIPN/A

Webwww.trivascular.com

Phone+1-707-5438800

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / CashN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net Margins-143.61%

Return on Equity-766.90%

Return on Assets-66.97%

Miscellaneous

EmployeesN/A

Outstanding Shares20,520,000

How to Become a New Pot Stock Millionaire

Trivascular Technologies (NASDAQ:TRIV) Frequently Asked Questions

What is Trivascular Technologies' stock symbol?

Trivascular Technologies trades on the NASDAQ under the ticker symbol "TRIV."

How were Trivascular Technologies' earnings last quarter?

Trivascular Technologies Inc (NASDAQ:TRIV) issued its quarterly earnings data on Monday, November, 9th. The medical device company reported ($0.66) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.71) by $0.05. The medical device company had revenue of $9.50 million for the quarter, compared to analyst estimates of $9.28 million. Trivascular Technologies had a negative return on equity of 766.90% and a negative net margin of 143.61%. The business's quarterly revenue was up 20.3% compared to the same quarter last year. During the same period last year, the company earned ($0.69) EPS. View Trivascular Technologies' Earnings History.

Who are some of Trivascular Technologies' key competitors?

Some companies that are related to Trivascular Technologies include Arctic Cat (ACAT), Shore Bancshares (SHBI), Chimerix (CMRX), Century Casinos (CNTY), Procera Networks (PKT), Ovid Therapeutics (OVID), EnerNOC (ENOC), PAM Transport (PTSI), Ocular Therapeutix (OCUL), Hardinge (HDNG), Sussex Bancorp (SBBX), Aratana Therapeutics (PETX), BCB Bancorp (BCBP), Civista Bancshares (CIVB), Arsanis (ASNS), Guidance Software (GUID), Telenav (TNAV) and resTORbio (TORC).

Has Trivascular Technologies been receiving favorable news coverage?

Media headlines about TRIV stock have trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm rates the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Trivascular Technologies earned a news sentiment score of 0.17 on Accern's scale. They also assigned media stories about the medical device company an impact score of 46.37 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of Trivascular Technologies?

Shares of TRIV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Trivascular Technologies' stock price today?

One share of TRIV stock can currently be purchased for approximately $5.87.

How big of a company is Trivascular Technologies?

Trivascular Technologies has a market capitalization of $120.75 million.

How can I contact Trivascular Technologies?

Trivascular Technologies' mailing address is 3910 Brickway Blvd, SANTA ROSA, CA 95403-1070, United States. The medical device company can be reached via phone at +1-707-5438800.

MarketBeat Community Rating for Trivascular Technologies (TRIV)

Community Ranking:		3.0 out of 5 ( )
Outperform Votes:		92 (Vote Outperform)
Underperform Votes:		61 (Vote Underperform)
Total Votes:		153

MarketBeat's community ratings are surveys of what our community members think about Trivascular Technologies and other stocks. Vote "Outperform" if you believe TRIV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRIV will underperform the S&P 500 over the long term. You may vote once every thirty days.

Trivascular Technologies (NASDAQ:TRIV) Analyst Ratings History

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details

(Data available from 4/19/2016 forward)

Trivascular Technologies (NASDAQ:TRIV) Earnings History and Estimates Chart

Earnings by Quarter for Trivascular Technologies (NASDAQ:TRIV)

Trivascular Technologies (NASDAQ TRIV) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/9/2015	Q3	($0.71)	($0.66)	$9.28 million	$9.50 million	View	N/A
8/4/2015	Q215	($0.73)	($0.73)	$8.78 million	$9.70 million	View	N/A
5/5/2015	Q115	($0.68)	($0.77)	$8.48 million	$9.00 million	View	Listen
3/3/2015	Q414	($0.65)	($0.72)	$9.54 million	$9.10 million	View	Listen
11/10/2014	Q314	($0.63)	($0.69)	$7.90 million	$7.88 million	View	N/A
8/6/2014	Q214	($0.66)	($0.87)	$7.54 million	$7.80 million	View	N/A
5/14/2014	Q1 14	($1.10)	($1.17)	$6.90 million	$7.00 million	View	N/A

(Earnings results data provided by Zacks Investment Research)

Trivascular Technologies (NASDAQ:TRIV) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Trivascular Technologies (NASDAQ TRIV) Insider Trading and Institutional Ownership History

Insider Trading History for Trivascular Technologies (NASDAQ:TRIV)

Trivascular Technologies (NASDAQ TRIV) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
4/22/2014	Douglas A Roeder	Director	Buy	833,333	$12.00	$9,999,996.00
4/22/2014	Enterprise Associates 12 New	Major Shareholder	Buy	583,333	$12.00	$6,999,996.00
4/22/2014	James E Flynn	Insider	Buy	1,065,000	$12.01	$12,790,650.00

(Data available from 1/1/2013 forward)

Trivascular Technologies (NASDAQ TRIV) News Headlines

Source:

Date	Headline
	John McDermott Steps Down as Chief Executive Officer of Endologix, Inc. finance.yahoo.com - February 21 at 4:40 PM
	Contrasting Trivascular Technologies (TRIV) and Amedica (AMDA) www.americanbankingnews.com - January 26 at 11:08 PM
	Head to Head Analysis: Trivascular Technologies (TRIV) vs. Its Competitors www.americanbankingnews.com - January 21 at 9:06 PM
	Analyzing Trivascular Technologies (TRIV) and Its Competitors www.americanbankingnews.com - January 20 at 9:14 PM
	Trivascular Technologies (TRIV) vs. Its Rivals Head-To-Head Review www.americanbankingnews.com - January 20 at 9:14 PM
	Financial Contrast: Trivascular Technologies (TRIV) versus Its Rivals www.americanbankingnews.com - January 20 at 3:16 AM
	Comparing Trivascular Technologies (TRIV) & Its Competitors www.americanbankingnews.com - January 19 at 3:32 AM
	Head to Head Survey: Trivascular Technologies (TRIV) vs. Its Competitors www.americanbankingnews.com - January 18 at 11:18 AM
	Financial Contrast: Trivascular Technologies (TRIV) and Its Peers www.americanbankingnews.com - January 17 at 3:18 PM
	Comparing Trivascular Technologies (TRIV) and Its Rivals www.americanbankingnews.com - January 17 at 11:40 AM
	Trivascular Technologies (TRIV) & Its Rivals Head-To-Head Review www.americanbankingnews.com - January 17 at 8:20 AM
	Trivascular Technologies (TRIV) versus The Competition Critical Review www.americanbankingnews.com - January 16 at 7:34 AM
	Critical Contrast: Trivascular Technologies (TRIV) vs. Its Competitors www.americanbankingnews.com - January 15 at 5:08 PM
	Trivascular Technologies (TRIV) vs. The Competition Head to Head Survey www.americanbankingnews.com - January 15 at 3:32 AM
	Head-To-Head Review: Trivascular Technologies (TRIV) vs. Its Competitors www.americanbankingnews.com - January 14 at 5:34 PM
	Trivascular Technologies (TRIV) vs. Its Competitors Head-To-Head Comparison www.americanbankingnews.com - January 14 at 9:30 AM
	Trivascular Technologies (TRIV) vs. Its Peers Head to Head Review www.americanbankingnews.com - January 13 at 1:34 PM
	Trivascular Technologies (TRIV) and The Competition Critical Contrast www.americanbankingnews.com - January 13 at 9:26 AM
	Head-To-Head Analysis: Trivascular Technologies (TRIV) and Its Rivals www.americanbankingnews.com - January 12 at 7:02 PM
	Trivascular Technologies (TRIV) versus The Competition Head to Head Analysis www.americanbankingnews.com - January 12 at 8:02 AM
	Head-To-Head Analysis: Trivascular Technologies (TRIV) vs. Its Peers www.americanbankingnews.com - January 12 at 8:02 AM
	Critical Contrast: Trivascular Technologies (TRIV) & The Competition www.americanbankingnews.com - January 10 at 11:14 PM
	Contrasting Trivascular Technologies (TRIV) & Its Peers www.americanbankingnews.com - January 10 at 5:30 PM
	Financial Comparison: Trivascular Technologies (TRIV) and Its Rivals www.americanbankingnews.com - January 9 at 8:08 AM
	Trivascular Technologies (TRIV) vs. The Competition Head-To-Head Analysis www.americanbankingnews.com - January 9 at 5:10 AM
	Trivascular Technologies (TRIV) vs. The Competition Financial Comparison www.americanbankingnews.com - January 8 at 11:06 PM
	Reviewing Trivascular Technologies (TRIV) & Its Peers www.americanbankingnews.com - January 8 at 12:04 PM
	Analyzing Trivascular Technologies (TRIV) & Its Competitors www.americanbankingnews.com - January 6 at 3:36 PM
	Head to Head Review: Trivascular Technologies (TRIV) versus Its Peers www.americanbankingnews.com - January 5 at 1:40 PM
	Head to Head Review: Trivascular Technologies (TRIV) vs. Its Peers www.americanbankingnews.com - January 4 at 3:32 AM
	Trivascular Technologies (TRIV) vs. Its Peers Financial Analysis www.americanbankingnews.com - January 3 at 7:06 PM
	Trivascular Technologies (TRIV) vs. The Competition Financial Analysis www.americanbankingnews.com - January 1 at 9:10 PM
	Critical Review: Trivascular Technologies (TRIV) and Its Peers www.americanbankingnews.com - January 1 at 9:26 AM
	Critical Review: Trivascular Technologies (TRIV) versus The Competition www.americanbankingnews.com - January 1 at 7:28 AM
	Head-To-Head Review: Trivascular Technologies (TRIV) and The Competition www.americanbankingnews.com - December 29 at 5:28 PM
	Contrasting RTI Surgical (RTIX) & Trivascular Technologies (TRIV) www.americanbankingnews.com - December 29 at 3:24 PM
	Financial Contrast: Trivascular Technologies (TRIV) versus The Competition www.americanbankingnews.com - December 28 at 12:16 AM
	Trivascular Technologies (TRIV) versus The Competition Financial Contrast www.americanbankingnews.com - December 27 at 3:54 PM
	Financial Review: Trivascular Technologies (TRIV) and Its Rivals www.americanbankingnews.com - December 27 at 5:34 AM
	Analyzing Trivascular Technologies (TRIV) & The Competition www.americanbankingnews.com - December 26 at 3:28 PM
	Reviewing Trivascular Technologies (TRIV) and Its Rivals www.americanbankingnews.com - December 25 at 11:06 AM
	Financial Review: Trivascular Technologies (TRIV) & Its Peers www.americanbankingnews.com - December 25 at 8:20 AM
	Critical Contrast: Trivascular Technologies (TRIV) and Its Peers www.americanbankingnews.com - December 25 at 3:28 AM
	Trivascular Technologies (TRIV) & Endologix (ELGX) Head to Head Review www.americanbankingnews.com - December 24 at 1:32 PM
	Trivascular Technologies (TRIV) versus Its Peers Critical Review www.americanbankingnews.com - December 24 at 1:32 PM
	Head to Head Comparison: Trivascular Technologies (TRIV) vs. The Competition www.americanbankingnews.com - December 24 at 8:05 AM
	Trivascular Technologies (TRIV) & Its Peers Critical Contrast www.americanbankingnews.com - December 23 at 5:24 PM
	Reviewing Trivascular Technologies (TRIV) and Its Peers www.americanbankingnews.com - December 23 at 1:24 AM
	Contrasting Trivascular Technologies (TRIV) & Its Rivals www.americanbankingnews.com - December 23 at 1:24 AM
	Contrasting ConforMIS (CFMS) and Trivascular Technologies (TRIV) www.americanbankingnews.com - November 20 at 11:19 AM

Trivascular Technologies (NASDAQ:TRIV) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Financials are not available for this stock.

Trivascular Technologies (NASDAQ TRIV) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff